Galenic formulations are personalized medicines prepared by pharmacists in their laborato ries. They are produced in small batches considering single patients’ characteristics, such as age, gender, allergies, and the like, thus contributing to responsible health. The production process is performed manually with the support of mechanic machines. This activity is time-consuming, prone to errors, and subject to quality variations. In this paper, we propose the integration of collaborative robots into the galenic formulation process to obtain several advantages, such as increased productivity, reduced variability, improved accuracy, and minimized risks associated with human error. Additionally, the use of robots can alleviate the physical burden on human operators, allowing them to focus on higher-level tasks that require critical thinking and decision-making. To achieve this goal, a software application, called PRAISE (Pharmaceutical Robotic and AI System for End users), has been developed; it is meant to support end users (i.e., pharmacists) in defining robot programs suitable to the case at hand. This application is conceived as an End-User Development (EUD) environment, which implements a hybrid interaction approach based on a natural language interface leveraging Large Language Models and a graphical interface to check and possibly revise the user-created robot programs. A user study carried out with nine pharmacists demonstrates the validity of the approach.

Gargioni, L., Fogli, D., Baroni, P. (2025). Preparation of Personalized Medicines through Collaborative Robots: A Hybrid Approach to the End-User Development of Robot Programs. ACM JOURNAL ON RESPONSIBLE COMPUTING, 2(3), 1-26 [10.1145/3715852].

Preparation of Personalized Medicines through Collaborative Robots: A Hybrid Approach to the End-User Development of Robot Programs

Luigi Gargioni;
2025

Abstract

Galenic formulations are personalized medicines prepared by pharmacists in their laborato ries. They are produced in small batches considering single patients’ characteristics, such as age, gender, allergies, and the like, thus contributing to responsible health. The production process is performed manually with the support of mechanic machines. This activity is time-consuming, prone to errors, and subject to quality variations. In this paper, we propose the integration of collaborative robots into the galenic formulation process to obtain several advantages, such as increased productivity, reduced variability, improved accuracy, and minimized risks associated with human error. Additionally, the use of robots can alleviate the physical burden on human operators, allowing them to focus on higher-level tasks that require critical thinking and decision-making. To achieve this goal, a software application, called PRAISE (Pharmaceutical Robotic and AI System for End users), has been developed; it is meant to support end users (i.e., pharmacists) in defining robot programs suitable to the case at hand. This application is conceived as an End-User Development (EUD) environment, which implements a hybrid interaction approach based on a natural language interface leveraging Large Language Models and a graphical interface to check and possibly revise the user-created robot programs. A user study carried out with nine pharmacists demonstrates the validity of the approach.
Articolo in rivista - Articolo scientifico
Human-centered computing; Collaborative and social computing devices; Com-puter systems organization; External interfaces for robotics
English
6-ott-2025
2025
2
3
1
26
13
open
Gargioni, L., Fogli, D., Baroni, P. (2025). Preparation of Personalized Medicines through Collaborative Robots: A Hybrid Approach to the End-User Development of Robot Programs. ACM JOURNAL ON RESPONSIBLE COMPUTING, 2(3), 1-26 [10.1145/3715852].
File in questo prodotto:
File Dimensione Formato  
Gargioni et al-2025-ACM J. Responsib. Comput-VoR.pdf

accesso aperto

Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Licenza: Creative Commons
Dimensione 5.13 MB
Formato Adobe PDF
5.13 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/605507
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
Social impact